Already have an account? Click here to login.

To download a copy of this document, please provide the following information.

Article Preview

Regenerative Medicine holds enormous potential for treating and ameliorating many chronic conditions for which we do not yet have viable treatment options, with the potential to address ever-increasing medical costs and improve the quality of life of countless sufferers and their families. However, the challenges associated with developing and delivering these therapies are daunting, often unique, and surpass those faced in the traditional pharmaceutical industry in both scope and scale.

In this article, Mark Osterman, Senior Vice President of Kineticos’ Biopharma Practice, outlines why a comprehensive strategic plan for commercialization that draws on the expertise and experience of the best people in the field and clearly defines potential obstacles is necessary to unlock the potential of such therapies.